Teva‘s Copaxone approved for preventative treament of MS – The drug is already approved to treat relapsing-remitting multiple sclerosis, where new symptoms occur suddenly or older symptoms become worse. The expanded approval allows for the drug’s use in people who have experienced a first episode of multiple sclerosis and have magnetic resonance imaging results consistent with the condition.
Pfizer and Bausch & Lomb in co-promote agreement for eyecare products – Pfizer Inc and Bausch & Lomb announced today a co-promotion agreement involving both companies’ prescription ophthalmic pharmaceuticals in the United States. The agreement will allow both companies to greatly increase the level of eye care industry support for these important medications that treat serious ophthalmic conditions.
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff